NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
Tenaris S.A. (NYSE: TS)
Class Period: May 1, 2014 - November 27, 2018
Lead Plaintiff Deadline: February 11, 2019
Join the action: https://www.zlk.com/pslra-1/tenaris-s-a-loss-form?wire=3
The lawsuit alleges: Tenaris S.A. made materially false and/or misleading statements throughout the class period and/or failed
to disclose that: (1) Tenaris’s CEO and Chairman, Paolo Rocca, knew that one of his company’s executives paid cash to government
officials from 2009 to 2012 to expedite compensation payments for the sale of Sidor; (2) this conduct would lead to Rocca being
charged in a graft scheme, and subject Tenaris, its affiliates, and/or executives to heightened governmental scrutiny; and (3) as a
result, Tenaris’s public statements were materially false and/or misleading at all relevant times. When the true details entered
the market, the lawsuit claims that investors suffered damages.
To learn more about the Tenaris S.A. class action contact jlevi@levikorsinsky.com.
Teladoc Health, Inc. (NYSE: TDOC)
Class Period: March 3, 2016 - December 5, 2018
Lead Plaintiff Deadline: February 11, 2019
Join the action: https://www.zlk.com/pslra-1/teladoc-health-inc-loss-form?wire=3
The lawsuit alleges that, during the class period, Teladoc Health, Inc. made materially false and/or misleading statements
and/or failed to disclose that: (i) Executive Vice President and Chief Operating Officer Mark Hirschhorn was engaged in an
inappropriate sexual relationship with a subordinate; (ii) Hirschhorn and this subordinate engaged in insider trading to provide
themselves with undue benefits; (iii) Hirschhorn caused the subordinate to receive promotions for which she was unqualified,
thereby negatively impacting the Company’s operations; (iv) the Company’s enforcement of its own purported employment and trading
policies were inadequate to prevent the foregoing conduct; and (v) as a result, the Company’s public statements were materially
false and misleading at all relevant times.
To learn more about the Teladoc Health, Inc. class action contact jlevi@levikorsinsky.com.
Ferroglobe PLC (NASDAQ: GSM)
Class Period: August 21, 2018 - November 26, 2018
Lead Plaintiff Deadline: March 25, 2019
Join the action: https://www.zlk.com/pslra-1/ferroglobe-plc-loss-form?wire=3
The lawsuit alleges: Ferroglobe PLC made materially false and/or misleading statements and/or failed to disclose that: (1) there
was excess supply of the Company’s products; (2) demand for the Company’s products was declining; (3) as a result, the pricing of
the Company’s products would be materially impacted; and (4) as a result of the foregoing, Defendants’ positive statements about
the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
To learn more about the Ferroglobe PLC class action contact jlevi@levikorsinsky.com.
ProShares Short VIX Short-Term Futures (NYSEArca: SVXY)
Class Period: Investors in ProShares Short VIX Short-Term Futures ETF pursuant to the May 15, 2017 Registration Statement
and/or between May 15, 2017 and February 5, 2018
Lead Plaintiff Deadline: April 1, 2019
Join the action: https://www.zlk.com/pslra-1/proshares-short-vix-short-term-futures-loss-form?wire=3
The lawsuit alleges that, during the class period, ProShares Short VIX Short-Term Futures made materially false and/or
misleading statements and/or failed to disclose that: According to the complaint in the Registration Statement and during the Class
Period, defendants made false and misleading statements and/or failed to disclose adverse information regarding the risks of
investing in the Fund. Specifically, the Registration Statement failed to disclose that the Fund was threatened with catastrophic
losses as a result of the Fund’s flawed design and the low-volatility environment and acute liquidity risks that existed during the
Class Period. In addition, during the Class Period defendants made similar false and misleading statements in numerous financial
reports and draft prospectuses and registration statements filed with the SEC.
To learn more about the ProShares Short VIX Short-Term Futures class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
